ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv evolution vaccine disease medicine

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Photo of carved bust in front of building labeled "Institut Pasteur"
Luc Montagnier, Virologist who Codiscovered HIV, Dies at Age 89
Natalia Mesa, PhD | Feb 11, 2022 | 3 min read
The Nobel laureate had courted controversy in recent years on vaccines and other matters.
Week in Review: June 15–19
Tracy Vence | Jun 19, 2015 | 3 min read
Eye on MERS; HIV vaccine design; evolution of Ebola; CRISPR meets optogenetics
A person lying on a bed checks the reading on a digital thermometer. A table with a bowl of oranges and various medications is in the background.
How Mild Is Omicron Really?
Dan Robitzski | Jan 14, 2022 | 9 min read
Early reports that Omicron causes less-severe disease than Delta seem to be borne out, but it’s not yet clear to what extent that’s due to the variant itself versus the populations it’s infecting.
HIV Evolves Vulnerability
Sabrina Richards | Oct 21, 2012 | 3 min read
In mutating to evade immune detection, HIV becomes susceptible to detection by different antibodies, suggesting new strategies for vaccination.
Templates for a vaccine?
Quentin J. Sattentau and Andrew J. McMichael | Oct 1, 2010 | 4 min read
By Quentin J. Sattentau and Andrew J. McMichael Templates for a vaccine? New tools for HIV-1 antibody-based vaccine design Env is shown as a transparent mesh consisting of three gp120 molecules (red) noncovalently linked to three gp41 molecules (not modeled) on the surface of an HIV-1 virion. An area marking the CD4 binding surface is labeled yellow. Bill Schief, Dept of Biochemistry / University of Washington, Seattle The human immunodef
New Weapons Against HIV
Ricki Lewis | Oct 1, 2001 | 8 min read
As the AIDS pandemic enters its third decade, viral resistance is beginning to counter the success of "highly active antiretroviral treatment" (HAART), the multidrug cocktails introduced in 1996. "Viral resistance is a significant problem, particularly for patients who began therapy in the pre-protease inhibitor era and who developed resistance to multiple reverse transcriptase inhibitors," says Robert Schooley, a professor of infectious diseases at the University of Colorado Health Sciences Cen
Studying SIV to Understand HIV
Myrna Watanabe | Jun 1, 2003 | 8 min read
Courtesy of Frank Kiernan  PICTURE OF HEALTH? This 15-year-old mangabey at the Yerkes National Primate Research Center in Atlanta has been SIV-infected for at least 10 years. In the past, physicians who treated AIDS patients understood that this deadly disease was one of immune deficiency. Their patients were immunosuppressed, subject to opportunistic infections, and had odd cancers. Today, because of continuing research on the human and primate immune systems and their responses to retr
How Some Vaccines Protect Against More than Their Targets
Shawna Williams | Nov 1, 2020 | 10+ min read
As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.

Run a Search

ADVERTISEMENT